Global Biological Safety Testing Market Growth (Status and Outlook) 2023-2029

Global Biological Safety Testing Market Growth (Status and Outlook) 2023-2029

Biological safety testing is carried out to ensure non-contamination of biopharmaceuticals and vaccines and to comply with regulations regarding the same. It is a major step towards the launch of innovative biopharmaceutical products. Biological safety testing is essential to ensure product safety, and ensure the quality of biopharmaceutical products. It is conducted to ensure that the drug-producing microbes or cells are free from microbial or viral pathogens, for process validation of virus inactivation, clearance capability during biopharmaceutical production, and to test these biological materials during biopharmaceutical production for verifying the identity and characteristics. In addition, it is also used to ensure the purity, sterility, and genetic stability of the production cell bank. Bioburden testing, sterility testing, adventitious agent’s detection test, cell line authentication and characterization tests, endotoxin tests, and residual host contaminant detection tests are the major biological safety tests. Biological safety testing is used in vaccine, cellular, and gene therapy products, blood and blood products, tissue and tissue products, and stem cell products. It is performed by contract testing laboratories on the behalf of drug developers. These laboratories are confronted with a number of ethical issues and tasked with maintaining confidentiality in handling the results.

LPI (LP Information)' newest research report, the “Biological Safety Testing Industry Forecast” looks at past sales and reviews total world Biological Safety Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Safety Testing sales for 2023 through 2029. With Biological Safety Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Safety Testing industry.

This Insight Report provides a comprehensive analysis of the global Biological Safety Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Safety Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Safety Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Safety Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Safety Testing.

The global Biological Safety Testing market size is projected to grow from US$ 2526.1 million in 2022 to US$ 5028.7 million in 2029; it is expected to grow at a CAGR of 10.3% from 2023 to 2029.

Rising need for biologics has resulted in unprecedented growth in number of biopharmaceutical companies. This increasing competition to develop therapeutically advanced drugs on a large scale has compelled manufacturers to improve on aspects such as productivity, cost efficiency, and deviations. Companies are thus implementing good manufacturing practices involving thorough biological testing at various levels of production cycles, thereby contributing toward market growth. Rising number of government initiatives to promote biological safety testing products is anticipated to drive overall market growth over the coming years. High microbial contamination rates and bioburden during pharmaceutical and biologics manufacturing are expected to drive government and private organizations to improve underlying biological safety practices. Moreover, presence of regulatory authorities to enforce significant safety standards is anticipated to provide boost adoption of testing tools. Stringent guidelines and recommendations laid down by these authorities increases incorporation of these tools by quality assurance technicians, thus providing a significant boost to the overall industry.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Safety Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Instruments
Services
Kits & Reagents

Segmentation by application
Vaccine Development
Blood Products
Stem Cell Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Charles River Laboratories International
Merck
Lonza Group
Avance Biosciences
SGS
Toxikon
NuAire

Please note: The report will take approximately 2 business days to prepare and deliver.